SOLM Stock Overview

Engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. More details

SOLM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	2/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 9.97% per year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

SOL S.p.A. Competitors

Johnson Matthey

LSE:JMAT

UK£2.4b

Croda International

LSE:CRDA

UK£4.7b

Novolipetsk Steel

LSE:NLMK

US$4.1b

RHI Magnesita

LSE:RHIM

UK£1.7b

Price History & Performance

Summary of share price highs, lows and changes for SOL
Historical stock prices
Current Share Price	€36.70
52 Week High	€36.75
52 Week Low	€32.70
Beta	0.52
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	93.77%
5 Year Change	264.81%
Change since IPO	459.45%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	SOLM	GB Chemicals	GB Market
7D	0%	3.8%	1.0%
1Y	n/a	-22.4%	10.4%

Return vs Industry: Insufficient data to determine how SOLM performed against the UK Chemicals industry.

Return vs Market: Insufficient data to determine how SOLM performed against the UK Market.

Price Volatility

Is SOLM's price volatile compared to industry and market?
SOLM volatility
SOLM Average Weekly Movement	n/a
Chemicals Industry Average Movement	6.1%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	11.0%
10% least volatile stocks in GB Market	2.7%

Stable Share Price: SOLM's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine SOLM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1927	7,015	Aldo Romario	www.solgroup.com

SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company offers oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use and liquefied natural gas. It also provides oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids.

SOL S.p.A. Fundamentals Summary

How do SOL's earnings and revenue compare to its market cap?
SOLM fundamental statistics
Market cap	€3.52b
Earnings (TTM)	€141.04m
Revenue (TTM)	€1.55b

25.3x

P/E Ratio

2.3x

P/S Ratio

Is SOLM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SOLM income statement (TTM)
Revenue	€1.55b
Cost of Revenue	€1.17b
Gross Profit	€375.98m
Other Expenses	€234.94m
Earnings	€141.04m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.56
Gross Margin	24.27%
Net Profit Margin	9.10%
Debt/Equity Ratio	55.0%

How did SOLM perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

24%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/31 21:02
End of Day Share Price	2025/01/02 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

SOL S.p.A. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Catharina Claes	Berenberg
Giovanni Selvetti	Berenberg
Massimo Bonisoli	Equita SIM S.p.A.